
Bindwell builds AI models that accelerate discovery of safer, more effective pesticides by predicting and optimizing bioactive structures. The company develops machine-learning and protein-structure models — including Foldwell, a reported alternative to AlphaFold that claims faster structure prediction — to design and test pesticide candidates in-house. Bindwell operates as a biotech R&D platform focused on computational chemistry, structural biology, and ML-driven candidate prioritization. Its technology is aimed at agrochemical developers and research teams working on pesticide discovery and safety assessment.

Bindwell builds AI models that accelerate discovery of safer, more effective pesticides by predicting and optimizing bioactive structures. The company develops machine-learning and protein-structure models — including Foldwell, a reported alternative to AlphaFold that claims faster structure prediction — to design and test pesticide candidates in-house. Bindwell operates as a biotech R&D platform focused on computational chemistry, structural biology, and ML-driven candidate prioritization. Its technology is aimed at agrochemical developers and research teams working on pesticide discovery and safety assessment.
What they do: AI models and wet-lab assays to design and prioritize safer, targeted pesticides
Founders: Tyler Rose and Navvye Anand
Latest reported raise: $6M seed (reported Nov 13, 2025)
Location & stage: San Francisco; early-stage / pre-seed to seed
Pesticide/agrochemical discovery and safety assessment
2024
Agriculture and Farming
$6,000,000
TechCrunch reported the round was co-led by General Catalyst and A.Capital with a personal check from Paul Graham.
“Backed by Y Combinator, General Catalyst, A.Capital, SV Angel, Character, Paul Graham, and others”
| Company |
|---|